PREVALENCE OF VIRULENCE GENES AMONG BULGARIAN NOSOCOMIAL AND CYSTIC FIBROSIS ISOLATES OF PSEUDOMONAS AERUGINOSA

Brazilian Journal Of Microbiology

Endereço:
Av. Prof. Lineu Prestes, 2415 Cidade Universitária
São Paulo / SP
Site: http://www.scielo.br/scielo.php?script=sci_serial&pid=1517-8382
Telefone: (11) 3813 9647
ISSN: 15178382
Editor Chefe: Adalberto Pessoa Junior
Início Publicação: 31/12/1970
Periodicidade: Trimestral
Área de Estudo: Microbiologia

PREVALENCE OF VIRULENCE GENES AMONG BULGARIAN NOSOCOMIAL AND CYSTIC FIBROSIS ISOLATES OF PSEUDOMONAS AERUGINOSA

Ano: 2010 | Volume: 41 | Número: 3
Autores: Ivan Mitov, Tanya Strateva, Boyka Markova
Autor Correspondente: Tanya Strateva | [email protected]

Palavras-chave: Pseudomonas aeruginosa, virulence genes, polymerase chain reaction, cystic fibrosis isolates, non-cystic fibrosis isolates

Resumos Cadastrados

Resumo Inglês:

The aim of this study was to evaluate the prevalence of some virulence genes among 202 Pseudomonas
aeruginosa isolates from cystic fibrosis (CF) patients (n=42) and non-CF in-patients (n=160) and to
analyze the values according to the patient groups, infection localization and antimicrobial resistance. The
following frequencies in all studied strains were established: algD (encoding GDP-mannose 6-
dehydrogenase AlgD) – 91.1%, pilB (type IV fimbrial biogenesis protein PilB) – 23.8%, nan1
(neuraminidase) – 21.3%, lasB (elastase LasB) – 100%, plcH (haemolytic phospholipase C precursor) –
91.6%, exoS (exoenzyme S) – 62.4%, and exoU (exoenzyme U) – 30.2%. The prevalence of nan1 was
significantly higher (P<0.01) in CF isolates (38.1%) than that in non-CF isolates (16.9%). The nan1–
positive CF strains were cultured from 16 patients with recurrent lung exacerbations. This study revealed a
statistically significant difference (P<0.01) between the portion of multidrug-resistant (MDR) nosocomial
P. aeruginosa strains containing a large number (5) of virulence genes (38.1%) and the respective part of
non-MDR isolates (17.6%). Moreover, pilB, exoU and nan1 manifested a higher spread (P<0.001) among
MDR than in non-MDR strains (respectively, 39.1% vs. 13.2%; 40.2% vs. 17.7% and 26.1% vs. 4.4%). In
conclusion, the dissemination of nan1 in CF isolates was moderate and correlated with the lower
proportion of patients with lung exacerbations. The molecular-genetic detection of this gene may be used
as an indirect measure of CF pulmonary disease evolution. Simultaneous determination of virulence factors
and antimicrobial resistance is the contemporary approach for examination of the microbiological aspects
of infections caused by P. aeruginosa.